CFDE Data Portal | Search LOC442041

	Label	Description
	LOC442041 Gene (Entity type)	ENSG00000230650 - zinc finger protein 532 pseudogene
	GSE80098 GSE80366 progesterone 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE264632 GSE264730 IDH1 inhibition 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE153354 TCF19 knockout CAL-27 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 2 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 6 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 11 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

LOC442041

ENSG00000230650 - zinc finger protein 532 pseudogene

GSE80098 GSE80366 progesterone 0 v 8 human up

A Gene Set from LINCS

GSE176008 pyridoxine 4 v 3 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human dn

A Gene Set from LINCS

GSE264632 GSE264730 IDH1 inhibition 0 v 2 human dn

A Gene Set from LINCS

GSE153354 TCF19 knockout CAL-27 0 v 1 human dn

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 2 v 8 human dn

A Gene Set from LINCS

GSE199107 tryptophan 6 v 7 human dn

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 5 human up

A Gene Set from LINCS

GSE239844 crizotinib 11 v 2 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.